myTomorrows

🙌 A warm welcome to our newest Mighties! We are very proud to introduce these superstars who recently joined myTomorrows. ⭐ Jonas Svensson – Senior Backend Engineer ⭐ Kristi Van Zyl – Site Manager ⭐ Madaline Kinlay – Real-World Data Associate ⭐ Alex Gleeson – Business Development Representative ⭐ Joseph Shepherd, PhD Shepherd – Medical Data Scientist ⭐ Theodor Cantero – Patient Navigator ⭐Joost den Iseger – Quality Assurance Officer ⭐ Rama Nusantara – Product Analyst ⭐ Dinesh . – Senior QA Test Engineer ⭐Pelle Wielinga – Senior Backend Engineer ⭐Zdena Lagova – Program Manager And we are still growing! 🚀 Check out our career opportunities here 👉 https://lnkd.in/etUEg8zG    #newjob #jobwithapurpose#newcareer #startuplife

We’re excited to share that myTomorrows has partnered with the CureLGMD2i Foundation!🚀 The mission of CureLGMD2i is to spread awareness, provide advocacy, and raise funds to research and support patients suffering from Limb Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9). 🔬LGMD2I/R9 is a form of Muscular Dystrophy that causes profound muscle wasting and weakness, primarily affecting the shoulders, thighs and hip muscles. While there is currently no cure for LGMD2I/R9, several investigational treatments are being explored in clinical trials. Unfortunately, accessing and navigating these trials can be challenging for those affected by the disease. 🌍 Our partnership seeks to simplify this process for patients and physicians. By using myTomorrows’ search engine, patients and physicians may more easily find relevant clinical trial options on a global scale. Additionally, myTomorrows’ patient navigators are available to provide guidance and support throughout the entire clinical trial journey, helping people with LGMD2I/R9 make the most informed decisions about their care. 🌅 Dr. Michel van Harten, CEO of myTomorrows, highlighted the value of this partnership, stating “This collaboration advances our commitment to empowering patients and healthcare professionals with the confidence and knowledge they need throughout their treatment journeys.” ➡️ Read more about this partnership here https://lnkd.in/dPNEaMEr #LGMD #LimbGirdle #MuscularDystrophy #Clinicaltrial #PatientSupport

Our very own Dennis Akkaya, Paris Asif and Rachele R. Bejjani will be soon attending the #EASD Annual Meeting in Madrid, Spain. This year’s event is particularly special as it marks the 60th anniversary of this meeting! 🎂🎈 The EASD Annual Meeting is one of the largest gatherings in the diabetes field, bringing together thousands of delegates from around the world. It’s an excellent opportunity to stay informed about the latest advancements, bridging the gap between discovery science and clinical practice. Dennis, Paris, and Rachelle are looking forward to diving into the latest innovations in the field! They are also eager to connect with physicians and industry professionals and discuss how myTomorrows can better support the #diabetes community. Interested in meeting up with our team? Book a meeting here https://lnkd.in/edCWr2Gz Or directly drop by our booth! #Diabetes #ClinicalTrials #HealthcareInnovation #clinicalpractice

Are you searching for a role at a company with an important mission? 🌍 Our founder started myTomorrows when he couldn’t find a clinical trial for his dad (who was diagnosed with cancer) in time to help him. We are a purpose-led company looking for people with endless ambition and an entrepreneurial mindset to come innovate with us. As a fast-growing startup in Amsterdam with 80+ people, we have 30+ nationalities and many great benefits, like a learning budget, flexible working, and a performance bonus just to name a few. Join us: 📐 Learn in an ever-evolving, dynamic environment. 🤝 Build up your skills in the healthcare sector. 💚 Know that you’re helping patients worldwide. ✔️Director Pharma Partneships https://lnkd.in/e62Ktu8X ✔️Clinical Site Manager Lead https://lnkd.in/e5mJx4aK ✔️Program Manager, Expanded Access Operations https://lnkd.in/e-KAHr-9 Our full list: https://lnkd.in/eXD3huwy   #WeAreMighty #newjob #hiring #newcareer

☀️Exciting News☀️ We’re thrilled to announce a new partnership between myTomorrows and PCE Pancreatic Cancer Europe. This union represents a collaborative effort to improve access to clinical trial information for patients affected by pancreatic cancer, their caregivers, and healthcare professionals.🚀 🌎 Pancreatic cancer is the fourth leading cause of cancer deaths, with a life expectancy of only 6-12 months at time of diagnosis and a 5-year survival rate of just 10%. The many challenges associated with this cancer include a lack of awareness about the disease among the public, late diagnosis, and limited treatment options. Through this partnership, Pancreatic Cancer Europe will utilize myTomorrows’ advanced search engine to provide up-to-date information on ongoing clinical trials, helping patients and healthcare professionals navigate this complex landscape more effectively. ➡️ Patient advocacy groups are making significant strides in helping patient through their treatment journey, and by deepening our collaboration, we aim to further strengthen their mission to support patients access to investigational treatment options. Dr. Michel van Harten Harten, CEO of myTomorrows, commented, “Collaborating with leading patient advocacy groups like Pancreatic Cancer Europe helps us extend our reach to more patients in need and empower them to navigate their treatment journeys with more confidence and knowledge, while enabling pharmaceutical companies to expand access throughout the drug development cycle.” 💪 Through this partnership, we strive to provide more accessible, clear, and supportive resources to those affected by pancreatic cancer. Learn more about this partnership and explore possible clinical trials here https://lnkd.in/eSJxPAt9 #HealthcareInnovation #PancreaticCancerAwareness #ClinicalTrials #PatientSupport #HealthTech#oncology

Join our growing team! Become a part of our dynamic group of Mighties with diverse backgrounds in Medical, Pharma, Tech, and Business. This is an exciting opportunity to join our ambitious company as it grows. With benefits like flexible working, a learning and development budget, and an annual performance bonus, you’ll be based in Amsterdam with a fast-growing company of 80+ people, with 30 nationalities, helping patients to know all their treatment options. 💚 We are looking for: ✔️Executive business assistant https://lnkd.in/eir_VZWp Our full list: https://lnkd.in/ePKc_KzQ   #WeAreMighty #newjob #hiring #newcareer

Curious about emerging treatments for Type 1 Diabetes? 🤔 Type 1 Diabetes is a condition where the body's immune system attacks and destroys the insulin-producing cells of the body. Consequently, managing this disease usually requires lifelong insulin administration and lifestyle adjustments to control blood sugar levels. 🔬Researchers are continuously exploring new investigational treatments with the goal of improving the quality of life of people living with Type 1 Diabetes. ☀️ Our latest blog provides a brief overview of these investigational therapies, offering you a starting point to understand the fundamentals of these approaches and how they work: https://lnkd.in/en35j3jK In this blog, we touch on: ✔️Immunotherapy ✔️Cell encapsulation ✔️Stem cell transplantation ✔️Gene therapy This blog is part of the myTomorrows disease awareness series. By providing a snapshot of these investigational therapies, our blog is designed to introduce patients, caregivers, and their families to these concepts, so they can keep themselves informed about ongoing research. #diabetes #type1diabetes #investigationaltreatment #medicalresearch #scientificresearch

Last week, we had another amazing Bonding Bites with the newest Mighties at myTomorrows! It was the opportunity to reflect on their first months, build connections, and enjoy a delicious meal together. 🌅 And of course, it was also the moment to receive our awesome myTomorrows sweaters - perfect for staying warm in the upcoming winter! 🚀 A big thank you to everyone who joined. Looking forward to more bonding moments in the future! 👏 #companyculture #newteam #healthtech #BondingBites #myTomorrows

As part of the myTomorrows disease awareness series, we are committed to helping patients, caregivers and loved ones to keep informed and learn how to navigate conditions and treatment journeys proactively. 🌅 This week we’re talking about Myotonic Dystrophy Type 1. It is a complex genetic disorder characterized by progressive muscle wasting and weakness. Besides the muscle, this condition may also impact other parts of the body, such as the heart, lungs, digestive system, eyes or brain.   For people with Myotonic Dystrophy Type 1, performing everyday activities can become increasingly difficult. While there is currently no cure for Myotonic Dystrophy Type 1, treatments focus on alleviating symptoms and improving quality of life. 🔬Do you want to know more about how Myotonic Dystrophy may affect someone’s health and daily life? Our blog provides comprehensive insights about this disease. https://lnkd.in/eZUm7S4U ✔️The genetic basis of Myotonic Dystrophy 1 ✔️What are the symptoms and complications? ✔️Importance of early diagnosis and ongoing care ✔️What types of investigational treatments are being researched? Whether you are affected by Myotonic Dystrophy Type 1 or want to learn more, our blog provides valuable knowledge and information about this disease.🚀 #DM1 #MyotonicDystrophy #MyotonicDystrophyAwareness

Have you considered how the diversity of clinical trial participants can impact the outcomes and approval of new drugs in the BioPharma industry? 🤔 Diversity, Equity, and Inclusion (DEI) are crucial to get a complete picture of a drug’s safety and efficacy across different populations. Despite its importance, the clinical trial participant population often doesn't reflect individuals in the real world. Recognizing this issue, the FDA is producing guidance documents to ensure that clinical studies appropriately test the product in a representative sample of the intended use population (read more here: https://lnkd.in/epvUTzX3). 🌎 However, there are barriers that hinder participation of specific groups in clinical trials, making it challenging to have a representative sample of the intended use population. Some of these barriers involve geographic and socioeconomic factors, access to information and language barriers and having a restrictive study design. ✔️ By focusing on recruiting patients from the diverse ethnicities that reflect the drug’s intended use population, partnering with community hospitals, and enhancing diversity among trial participants and researchers, the BioPharma industry can ensure more comprehensive and reliable research outcomes, aligning with FDA guidelines and avoiding costly delays and compliance issues.   ➡️ At myTomorrows, we strive to support BioPharma to make clinical trials more accessible and inclusive. By acting as a connected hub between patients, advocacy groups, physicians, and BioPharma, we aim to directly address some of these barriers. Curious to know more about DEI in clinical trial recruitment? Read our blog: https://lnkd.in/eSTQT2ZC Together, we can ensure a brighter, more inclusive future for medical research. #ClinicalTrials #DEI #DiversityEquityInclusion #HealthEquity #MedicalResearch #InclusiveResearch